Printer Friendly

Strategika, Inc. (d.b.a. Tiens Biotec Group (USA), Inc.) Files Application for Listing on Amex.

STRATEGIKA, INC. (OTC Bulletin Board: SGKA), a corporation organized under the laws of the State of Delaware and doing business as Tiens Biotec Group (USA) Inc., announced today that it made an application to become a listed company on the American Stock Exchange on December 8, 2003. Tiens Biotec Group (USA), Inc. is the American branch of Tianshi International Holdings Group Ltd., a global enterprise corporation with headquarters in Beijing, China, and production plants in Tianjin, China's third largest city.

Tianshi's main business operations are conducted through Tianjin Tianshi Biodevelopment Co. Ltd., a foreign investment joint venture incorporated in the People's Republic of China. Since its founding in 1995, Tianshi Group has maintained an average annual growth of 170 percent. After developing numerous domestic product lines, including nutritional supplements, general food commodities and medical equipment, Tianshi has diversified into manufacturing, trade, real estate development, education, culture, services, travel, transportation and financial services. Currently Tianshi has branches in over 90 countries in the Americas, Europe, Asia and surrounding regions. In 2002, the company was named one of the 50 Major Health Product Enterprises of China.

In September 2003, Tianshi International completed a successful reverse merger with Strategika, Inc. and plans to change the company name to

Tiens Biotec Group (USA), Inc. as soon as practical. For the nine months ended September 30, 2003, Strategika, Inc. (d.b.a. Tiens Biotec Group (USA), Inc.) reported in its 10Q/A a net income of $14,615,235, compared to net income of $1,314,351 for the same period in 2002. The increase in earnings resulted primarily from the reverse merger. The increase in earnings resulted primarily from expansion of international sale forces.

"We are delighted that Tiens has chosen to make an application to the American Stock Exchange. After the review process, we look forward to welcoming them to our listed company community. The AMEX is committed to looking to Asia for more companies in '04," said John McGonegal, Vice President, AMEX Equity sales and Issuer Services.

Said Jin Yuan Li, President of Tianshi International Holdings Group, "We very pleased to apply for listing on the American Stock Exchange. We are confident that our business in the United States will benefit people in both nations, including our customers, strategic partners and shareholders."

Making application to be listed on the American Stock Exchange does not guarantee acceptance.

About Strategika, Inc.

Strategika, Inc. (BULLETIN BOARD: SGKA) is a corporation organized under the laws of the State of Delaware. On September 9, 2003, Strategika completed a reverse merger with Tianshi International Holdings Group Limited, a corporation organized under the laws of the British Virgin Islands. The TIANSHI stockholders are Jin Yuan Li, Wen Jun Jiao and Yu Peng Yan, all Chinese Nationals. TIANSHI owns 80 percent of Tianjin Tianshi Biodevelopment Co. Limited (Tianshi China), which conducts TIANSHI's main business operations. Tianshi China is a foreign investment joint venture incorporated in the People's Republic of China and based in Tianjin, PRC. Tianshi China is primarily engaged in the research, development, manufacturing and marketing of health care products, including herbal products, vitamin and mineral supplements and personal care products. Tianshi China has developed seven major product series and produced 45 types of healthcare products. Of these, 27 are healthcare food products, all of which have obtained the "Health Food Certificates" issued by the PRC Ministry of Health to be sold in the PRC. The seven major product series are: High-Calcium Series, Immune System Adjustment Series, Nutrient Supplements Series, Cholesterol Adjustment Series, High-Fiber Series, Heart and Brain Improvement Series and Personal Care Series. Under the High-Calcium series, Tianshi China has conducted extensive research and developed Tianshi Hyperglycemia High Calcium Nutrient Powder.

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Strategika, Inc. ("the Company" or "we" or "our"), or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward- looking statements, including that the Company's current revenue levels are not necessarily indicative of its future revenue levels or future financial performance. The Company's future operating results are dependent upon many factors, including but not limited to: (a) those risks and uncertainties related to general economic conditions in China, including regulatory factors that may affect such economic conditions; (b) whether we are able to manage our planned growth efficiently and operate profitable operations, including whether our management will be able to identify, hire, train, retain, motivate and manage required personnel or that management will be able to successfully manage and exploit existing and potential market opportunities; (c) whether we are able to generate financing to sustain and grow our operations; (d) whether we are able to successfully fulfill our primary requirements for cash which are explained below under "Liquidity and Capital Resources (e) our financial results for the 3 months and 9 months ending September 30, 2003, are not necessarily indicative of future financial results.
 CONTACTS:
 Stanley Wunderlich Jin Yuan Li
 Consulting For Strategic Growth I, Ltd. President
 Public Relations Tel: 86-22-8213-7618
 Corporate Development Consultants Fax: 86-22-8213-7613
 Tel: 800-625-2236 E-mail:wangyan@tiens.com.cn
 Fax: 212-697-0910 http://www.tiens-bio.com/
 E-mail: cfsg@consultant.com



CONTACT: Stanley Wunderlich, Consulting For Strategic Growth I, Ltd., Public Relations, Corporate Development Consultants, 1-800-625-2236, or fax, +1-212-697-0910, cfsg@consultant.com; or Jin Yuan Li, President, Tianshi International Holdings Group, +86-22-8213-7618, or fax, +86-22-8213-7613, wangyan@tiens.com.cn

Web site: http://www.tiens-bio.com/
COPYRIGHT 2003 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:1USA
Date:Dec 29, 2003
Words:932
Previous Article:Vodafone Extends Partner Community With Second MTC Agreement.
Next Article:Tecnomatix to Present at the Sixth Annual Needham Growth Conference.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters